130 related articles for article (PubMed ID: 23086776)
1. Usefulness of CD11a and CD18 in flow cytometric immunophenotypic analysis for diagnosis of acute promyelocytic leukemia.
Zhou Y; Jorgensen JL; Wang SA; Ravandi F; Cortes J; Kantarjian HM; Medeiros LJ; Konoplev S
Am J Clin Pathol; 2012 Nov; 138(5):744-50. PubMed ID: 23086776
[TBL] [Abstract][Full Text] [Related]
2. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR antigen-positive acute promyelocytic leukemia.
Mendoza AS; Qing X; Dungo M; Lasky J; Panosyan E; Cai J
Exp Mol Pathol; 2016 Oct; 101(2):197-200. PubMed ID: 27544027
[TBL] [Abstract][Full Text] [Related]
4. Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative Non-APL leukemia.
Mosleh M; Mehrpouri M; Ghaffari S; Saei Z; Agaeipoor M; Jadali F; Satlsar ES; Gholampour R
Scand J Clin Lab Invest; 2020; 80(2):87-92. PubMed ID: 31829759
[TBL] [Abstract][Full Text] [Related]
5. Expression of cell-surface antigens in acute promyelocytic leukaemia.
Paietta E
Best Pract Res Clin Haematol; 2003 Sep; 16(3):369-85. PubMed ID: 12935957
[TBL] [Abstract][Full Text] [Related]
6. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
[TBL] [Abstract][Full Text] [Related]
7. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
8. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia.
Rahman K; Gupta R; Singh MK; Sarkar MK; Gupta A; Nityanand S
Int J Lab Hematol; 2018 Apr; 40(2):144-151. PubMed ID: 28984423
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometry rapidly identifies all acute promyelocytic leukemias with high specificity independent of underlying cytogenetic abnormalities.
Dong HY; Kung JX; Bhardwaj V; McGill J
Am J Clin Pathol; 2011 Jan; 135(1):76-84. PubMed ID: 21173127
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic immunophenotype of acute promyelocytic leukemia before and early during therapy with all-trans retinoic acid.
Horna P; Zhang L; Sotomayor EM; Lancet JE; Moscinski LC
Am J Clin Pathol; 2014 Oct; 142(4):546-52. PubMed ID: 25239423
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
12. A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots.
Kárai B; Habók M; Reményi G; Rejtő L; Ujfalusi A; Kappelmayer J; Hevessy Z
Ann Hematol; 2019 Jun; 98(6):1413-1420. PubMed ID: 30830246
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
[TBL] [Abstract][Full Text] [Related]
14. [Immunophenotypic analysis of leukemia promyelocytes in 71 patients with acute promyelocytic leukemia].
Liu Y; Chen YT; Li JX; Zhang SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):806-11. PubMed ID: 22931633
[TBL] [Abstract][Full Text] [Related]
15. [Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia].
Wang YZ; Chang Y; Zhu HH; Qin YZ; Li JL; Fu JY; Li LD; Chen SS; Huang XJ; Lu DP; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):427-32. PubMed ID: 16800913
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry.
Fang H; Wang SA; Hu S; Konoplev SN; Mo H; Liu W; Zuo Z; Xu J; Jorgensen JL; Yin CC; El Hussein S; Jelloul FZ; Tang Z; Medeiros LJ; Wang W
Cytometry B Clin Cytom; 2022 Jul; 102(4):283-291. PubMed ID: 35716019
[TBL] [Abstract][Full Text] [Related]
17. The CD9
Ren F; Zhang N; Xu Z; Xu J; Zhang Y; Chen X; Tan Y; Chang J; Wang H
Int J Lab Hematol; 2019 Apr; 41(2):168-175. PubMed ID: 30315692
[TBL] [Abstract][Full Text] [Related]
18. [Detection and analysis of immune molecules in leukemia cell surfaces of acute promyelocytic leukemia].
Dong T; Jiang Y; Li Z; Ouyang H; Zhang Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):664-667. PubMed ID: 28502306
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.
Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G
Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365
[TBL] [Abstract][Full Text] [Related]
20. [Application of immunophenotypic analysis and molecular genetics in the diagnosis of acute promyelocytic leukemia].
Gong JY; Li YY; Li CW; Wang YS; Liu Y; Wang C; Ru K; Mi YC; Wang JX; Wang HJ
Zhonghua Xue Ye Xue Za Zhi; 2019 Apr; 40(4):288-293. PubMed ID: 31104439
[No Abstract] [Full Text] [Related]
[Next] [New Search]